Elevated PARP1 polymerase in HER2+ breast cancer may confer susceptibility to PARP inhibitor drugs.
Two highly acclaimed cancer researchers, Ravi Bhatia, M.D., and Smita Bhatia, M.D., MPH, will join UAB in January 2015.
In January, Ravi Bhatia, M.D., will take the helm as director of the Division of Hematology and Oncology and as deputy director of the UAB Comprehensive Cancer Center.
PNP Therapeutics, UAB and Southern Research Institute work abolishes otherwise unmanageable human cancers in preclinical rodent studies.
Clinicians will collaborate with local physicians, offering patients updated treatment recommendations and access to cutting-edge research.
Biomarkers could tailor preventative or therapeutic aspirin regimens by predicting patients’ response.